NIH-funded research NIH-funded research

Investigating heart health and inflammation in women living with HIV

Official title: Sex-specific factors, inflammation and vascular health across the lifespan in women living with HIV

Funded at Johns Hopkins University · NIH-11009061 · Data updated 2026-11-12

This study is looking at how HIV impacts heart health in women as they get older, aiming to find out why women with HIV are more likely to develop heart disease, so we can create better ways to prevent and treat it just for them.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJanuary 8, 2024
Project endDecember 31, 2030
Funding year2025
Award (this year)$281,116
NIH project number5R35HL172680-02
Project IDNIH-11009061 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women living with HIV, particularly those who are at risk for cardiovascular disease.

Less likely to help

Patients who are not living with HIV or who do not have cardiovascular disease risk factors may not benefit from this research.

What this research studies

This research focuses on understanding how HIV affects cardiovascular health in women, particularly as they age. It aims to identify specific factors that contribute to increased heart disease risk in women living with HIV, which is significantly higher than in uninfected women. The study will explore the role of chronic inflammation and other biological markers in heart disease development. By examining these factors, the research seeks to improve prevention and treatment strategies tailored for this high-risk group.

Why it matters

Potential benefit: If successful, this research could lead to better heart disease prevention and treatment options specifically designed for women living with HIV.

How similar studies have gone: Previous research has shown that understanding sex-specific health issues in HIV can lead to significant advancements in treatment, indicating a promising avenue for this study.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Hays, Allison G — Johns Hopkins University
  • Study coordinator: Hays, Allison G

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.